These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1828422)

  • 1. A variant of nephrogenic diabetes insipidus: V2 receptor abnormality restricted to the kidney.
    Knoers N; Monnens LA
    Eur J Pediatr; 1991 Mar; 150(5):370-3. PubMed ID: 1828422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
    N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.
    Brink HS; Derkx FH; Boomsma F; Brommer EJ; Schalekamp MA
    Neth J Med; 1993 Aug; 43(1-2):5-12. PubMed ID: 8232694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal homeostasis of fibrinolysis in nephrogenic diabetes insipidus in spite of defective V2- receptor-mediated responses of tissue plasminogen activator release.
    Brommer EJ; Brink H; Derkx FH; Schalekamp MA; Stibbe J
    Eur J Clin Invest; 1990 Feb; 20(1):72-8. PubMed ID: 2138555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic responses to 1-desamino-8-D-arginine-vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Knoers N; Brommer EJ; Willems H; van Oost BA; Monnens LA
    Nephron; 1990; 54(4):322-6. PubMed ID: 2109264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposed cause of marked vasopressin resistance in a female with an X-linked recessive V2 receptor abnormality.
    Moses AM; Sangani G; Miller JL
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1184-6. PubMed ID: 7714087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal response of factor VIII and von Willebrand factor to 1-deamino-8D-arginine vasopressin in nephrogenic diabetes insipidus.
    Brenner B; Seligsohn U; Hochberg Z
    J Clin Endocrinol Metab; 1988 Jul; 67(1):191-3. PubMed ID: 3132483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidus. Evidence for a pre-cyclic AMP V2 receptor defective mechanism.
    Bichet DG; Razi M; Arthus MF; Lonergan M; Tittley P; Smiley RK; Rock G; Hirsch DJ
    Kidney Int; 1989 Nov; 36(5):859-66. PubMed ID: 2559238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absent factor VIII response to synthetic vasopressin analogue (DDAVP) in nephrogenic diabetes insipidus.
    Kobrinsky NL; Doyle JJ; Israels ED; Winter JS; Cheang MS; Walker RD; Bishop AJ
    Lancet; 1985 Jun; 1(8441):1293-4. PubMed ID: 2860491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two distinct pathophysiological mechanisms in congenital nephrogenic diabetes insipidus.
    Moses AM; Miller JL; Levine MA
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1259-64. PubMed ID: 3131381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A low affinity vasopressin V2-receptor in inherited nephrogenic diabetes insipidus.
    Luzius H; Jans DA; Grünbaum EG; Moritz A; Rascher W; Fahrenholz F
    J Recept Res; 1992; 12(3):351-68. PubMed ID: 1387165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Congenital nephrogenic diabetes insipidus].
    Thibonnier M
    Rev Prat; 1994 May; 44(9):1169-72. PubMed ID: 7939338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivatives of somatic cell hybrids which carry the human gene locus for nephrogenic diabetes insipidus (NDI) express functional vasopressin renal V2-type receptors.
    Jans DA; van Oost BA; Ropers HH; Fahrenholz F
    J Biol Chem; 1990 Sep; 265(26):15379-82. PubMed ID: 2168411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A family case of nephrogenic diabetes insipidus.
    Okayasu T; Shigihara K; Kobayashi N; Ishikawa A; Fukushima N; Takase A; Hattori S; Nakajima T; Shishido T; Agatsuma Y
    Tohoku J Exp Med; 1990 Oct; 162(2):137-45. PubMed ID: 2097813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for intact V1-vasopressin receptors in congenital nephrogenic diabetes insipidus.
    Knoers N; Janssens PM; Goertz J; Monnens LA
    Eur J Pediatr; 1992 May; 151(5):381-3. PubMed ID: 1396896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrogenic diabetes insipidus: identification of the genetic defect.
    Knoers N; van den Ouweland A; Dreesen J; Verdijk M; Monnens LA; van Oost BA
    Pediatr Nephrol; 1993 Oct; 7(5):685-8. PubMed ID: 8251344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin increases urinary albumin excretion in rats and humans: involvement of V2 receptors and the renin-angiotensin system.
    Bardoux P; Bichet DG; Martin H; Gallois Y; Marre M; Arthus MF; Lonergan M; Ruel N; Bouby N; Bankir L
    Nephrol Dial Transplant; 2003 Mar; 18(3):497-506. PubMed ID: 12584270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two novel mutations in the vasopressin V2 receptor gene in unrelated Japanese kindreds with nephrogenic diabetes insipidus.
    Tsukaguchi H; Matsubara H; Aritaki S; Kimura T; Abe S; Inada M
    Biochem Biophys Res Commun; 1993 Dec; 197(2):1000-10. PubMed ID: 8267567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal fibrinolytic responses to 1-desamino-8-D-arginine vasopressin in patients with nephrogenic diabetes insipidus caused by mutations in the aquaporin 2 gene.
    van Lieburg AF; Knoers VV; Mallmann R; Proesmans W; van den Heuvel LP; Monnens LA
    Nephron; 1996; 72(4):544-6. PubMed ID: 8730418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Kidney tubular transport disorders. Nephrogenic diabetes insipidus].
    Ishikawa S
    Nihon Rinsho; 1989 Jul; 47(7):1641-5. PubMed ID: 2530373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.